Litcius/Paper detail

Leukemic Stem Cell (CD34+/CD38–/TIM3+) Frequency in Patients with Acute Myeloid Leukemia: Clinical Implications

Mahmoud M.I. Mohamed, Salah Aref, Mohamed Al Agdar, Mohamed Mabed, Ahmed M.A. El-Sokkary

2021Clinical Lymphoma Myeloma & Leukemia15 citationsDOI

Topics & Concepts

CD34CD38Myeloid leukemiaMedicineInduction chemotherapyInternal medicineOncologyLeukemiaBone marrowProportional hazards modelStem cellGastroenterologyMyeloidChemotherapyImmunologyBiologyGeneticsAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationChronic Myeloid Leukemia Treatments
Leukemic Stem Cell (CD34+/CD38–/TIM3+) Frequency in Patients with Acute Myeloid Leukemia: Clinical Implications | Litcius